样式: 排序: IF: - GO 导出 标记为已读
-
Response to Hasan et al., “[Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T-cell lymphoma: a retrospective cohort study]” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-09-07 Elaine Flynn BA, Nicholas Leonard MD, Ryan Svoboda MD MS
-
A study of ultralow dose rituximab as adjuvant to standard of care in treatment of significant and extensive pemphigus vulgaris: A case series J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-09-07 Nayankumar H. Patel MD DVL, Jignaben K. Padhiyar MD DVL, Jahnvi R. Patel MBBS, Kathak A. Patel MBBS, Megha P. Lakum MBBS, Yaksh Pradeep Oza MBBS, Harisiddhi Bharatbhai Patel MBBS, Prashant Bhikhabhai Chaudhary MBBS
-
Drug survival of interleukin 17 inhibitors after switch from interleukin 23 inhibitors in psoriasis: An observational cohort study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-09-07 Daniella Kushnir-Grinbaum MD, Michael Ziv MD
-
The role of ultraviolet-induced fluorescence dermatoscopy for the detection of multiple aggregated yellow-white globules in basal cell carcinoma J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-09-07 Cristian Navarrete-Dechent MD, Pawel Pietkiewicz MD PhD, Gisel Astronave MD, Nadeem G. Marghoob MD, Stephen W. Dusza DrPH, Josefina Lorenzoni MD, Manuela Boleira MD, Michael Cristopher MD, Rosario Aguero MD, Sergio Bustos MD, Natalia Jaimes MD, Maria Kurpis MD, Leonel Hidalgo MD, Alvaro Abarzua-Araya MD, Pablo Zoroquiain MD PhD, Pablo Uribe MD PhD, Consuelo Cárdenas MD, Katherine Droppelmann MD MSc
-
Addressing vancomycin adverse cutaneous reactions J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-30 Warren R. Heymann MD
-
This month in JAAD: November 2024 J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-28 Dirk M. Elston MD
-
Dermatologic toxicities of antibody-drug conjugates J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-23 Christian Gronbeck MD, Matthew J. Hadfield MD, Jane M. Grant-Kels MD
Antibody-drug conjugates (ADCs) are a new and emerging category of oncologic treatments that combine the target specificity of a monoclonal antibody with a cytotoxic payload. These drugs are associated with unique cutaneous toxicities that vary across agents. Currently, there are eleven ADCs with regulatory approval for solid and liquid tumors and over 80 ADCs currently in clinical development, it
-
Educational intervention targeting primary care residents improves skin cancer recognition in patients with skin of color J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-23 Jennifer J. Watters DPT, Maria C. Bell MD, James E. Slaven MS, Syril Keena T. Que MD MPH
-
Implementing Apple AirTag to provide real-time tracking of histopathology specimens during transportation J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-23 Sujitha Yadlapati MD, Drew Taylor MD, Stanislav N. Tolkachjov MD
-
Continuum of light sensitivity in atopic dermatitis: A retrospective analysis of 139 cases in Scotland J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-23 Chayada Chaiyabutr MD, Robert Dawe MD, Andrea Lesar MSc, Sally H. Ibbotson MD
Previous reports have characterized photosensitivity in atopic dermatitis (AD), but with differences in terminology and criteria. This study aims to assess outcomes in 139 patients with AD referred for photodiagnostic testing and to establish diagnostic criteria for photosensitivity in AD. Clinical and photodiagnostic data were reviewed, categorizing photosensitivity into photoexacerbated AD, photosensitive
-
Approach to Mycosis Fungoides in children: Consensus-based recommendations J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-23 Alex Zvulunov MD MHA, Holly Neale MD, Jonah Stern MD, Pasqualina Santaguida PT PhD, Amy Buros Stein PhD, Mark Koh MD, Lawrence F. Eichenfield MD, Joan Guitart MD, Matthias Goebeler MD, Julia Scarisbrick MD, Rein Willemze MD, Carrie C. Coughlin MD MPH, Renu George MD, Valeria Brazzelli MD, Márta Marschalkó MD PhD, Irena Belousova MD PhD, Christiane Querfeld MD, Martine Bagot MD PhD, Jacek C. Szepietowski
Pediatric Mycosis fungoides (MF) management extrapolates from adult guidelines, despite differing clinical aspects. Recommendations are essential to address unique challenges in this distinct patient group. This project aims to derive consensus recommendations for pediatric MF management. Experts from pediatric dermatology, general dermatology, dermatopathology, and pediatric hematology-oncology ( = 83)
-
Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema—Findings from the Danish Skin Cohort J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-22 Maria O. Christensen MD, Johan Sieborg MS, Lea K. Nymand MS, Emma Guttman-Yassky MD PhD, Khaled Ezzedine MD PhD, Christoph Schlapbach MD PhD, Sonja Molin MD, Jianzhong Zhang MD, Claus Zachariae MD DMSci, Simon F. Thomsen MD PhD DMSci, Jacob P. Thyssen MD PhD DMSci, Alexander Egeberg MD PhD DMSc
Topical corticosteroid phobia (TOPICOP) is associated with poor treatment adherence and is common among patients with skin disease. Knowledge about corticosteroid phobia and treatment adherence among patients with chronic hand eczema (CHE) is limited. To investigate patient-reported outcomes regarding topical corticosteroids (TCSs), and their impact on treatment adherence in patients with CHE. Patients
-
Response to: Bocquel et al, “Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-22 Hui Xin See Tow, Agnes Yeok-Loo Lim MD PhD, Ci-En Ellie Choi MBBS MRCP MMed
-
Tralokinumab as an effective alternative after dupilumab treatment failure in moderate-to-severe atopic dermatitis: A real-world study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-21 Shaina E. George BS, JiaDe Yu MD MS
-
Response to “No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-20 Deesha Desai BS, Michelle Sikora BS, Ambika Nohria BA, Avrom S. Caplan MD, Mario Lacouture MD, Jerry Shapiro MD, Kristen I. Lo Sicco MD
-
Factors associated with residual tumor at time of Mohs micrographic surgery for basal cell and squamous cell carcinomas J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-19 Katherine G. Thompson MD, Raghav Tripathi MD MPH, Jaroslaw Jedrych MD, Kristin P. Bibee MD PhD, Jeffrey F. Scott MD, Elise Ng MD
Residual tumor is not always clinically apparent following biopsy of cutaneous carcinomas, which may prompt patients to question the need for definitive treatment. We investigated the percentage of cases in which residual tumor was histologically present at the time of Mohs micrographic surgery (MMS) for basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) and investigated factors associated
-
Erythema multiforme associated with the immune checkpoint inhibitors: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-19 Hannah Godfrey BS, Zachary Leibovit-Reiben BS, Patrick Jedlowski MD, Rebecca Thiede MD
-
To Google, or not to Google, that is the question: Ethics of internet searches when caring for incarcerated individuals J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-19 Timothy Klufas BA, Shannon Hanggodo BS, Albert E. Zhou MD PhD, Campbell L. Stewart MD, Jun Lu MD, Jane M. Grant-Kels MD
-
Ethical considerations of foregoing sensitive skin examinations J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-19 Sach Thakker BS, Hannah Verma BA, Shari R. Lipner MD PhD
-
Extrapolating the speed of psoriasis clearance: A comparative analysis of biologic agents in clinical trials J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-19 Creighton Pfau BS, Katie K. Lovell BS, Steven R. Feldman MD PhD
-
Response to Bennett et al., “[Correction to excision margins for melanoma in situ on the head and neck]” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-16 Divya Srivastava MD, Rajiv I. Nijhawan MD
-
Response to Chawla et al, “Response to Vu et al’s “Efficacy of moxifloxacin as a mono-antibiotic therapy for hidradenitis suppurativa: A retrospective cohort study”” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-16 Don Vu, Megan Park BSc, Raed Alhusayen MBBS MSc
-
Future research directions regarding safety of spironolactone for dermatologic conditions J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-16 Rachel C. Hill BS, Yu Wang MD, Bilal Shaikh MS, Shari R. Lipner MD PhD
-
Response to Costa Fechine et al’s “Correlation of clinical and trichoscopy features with the degree of histologic inflammation in lichen planopilaris and frontal fibrosing alopecia in a cross-sectional study” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-16 Jeffrey N. Li MD, Andrea Sechi MD, Antonella Tosti MD
-
Response to Vu et al, “Efficacy of moxifloxacin as a mono-antibiotic therapy for hidradenitis suppurativa: A retrospective cohort study” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-16 Sumir Chawla MD, Neil P. Patel PhD
-
Reaction on permanent make-up: Don't forget sarcoidosis! J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-16 Nicolas Kluger MD PhD
-
Color me unhealthy: The toxic health effects of colorism J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-16 Kathyana P. Santiago Mangual BA, Heather Gochnauer MD, Arianne Shadi Kourosh MD MPH
-
Allergens and consumer warnings in at-home acrylic manicure kits J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-13 Hannah R. Riva MPAS, Carina M. Woodruff MD
-
Anifrolumab in recalcitrant cutaneous dermatomyositis: A multicenter retrospective cohort study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-12 Katharina S. Shaw MD, Kimberly B. Hashemi MD, Rochelle L. Castillo MD MS, Elizabeth Rainone ALB, Allen W. Ho MD, Philip J. Kahn MD, Vikash S. Oza MD, Alisa Femia MD, Ruth Ann Vleugels MD MPH MBA
-
A sticky mess—Are moisturizers overused in dermatitis care? J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-10 Susan Nedorost MD
Microbial dysbiosis is increasingly understood to influence allergic sensitization and skin barrier defects in dermatitis. Occlusion, such as from moisturizers, fosters microbial dysbiosis, and increases itch in many patients with dermatitis. Nevertheless, use of moisturizers in dermatitis remains part of dermatologic guidelines. This is a review of the evidence of benefits and adverse effects of moisturizers
-
This month in JAAD Case Reports: October 2024 J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-10 Abby S. Van Voorhees MD
-
This month in JAAD International: October 2024: Non-surgical management of actinic keratoses J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-10 Jonathan Kantor MD MSc MSCE
-
Efficacy of colchicine treatment for aphthous ulcers in pediatric patients: A retrospective review J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-09 Ananya Shah BA, Hilary Kunkel MD, Nessa Aghazadeh Mohandesi MD, Megha Tollefson MD
-
Geographic trends in psoriasis injectable biologic prescriptions by dermatologists among Medicare beneficiaries J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-09 Qiwei Wilton Sun BA, Hao Feng MD MHS, Jeffrey M. Cohen MD
-
Direct immunofluorescence testing for skin and mucosal ulcerations: A retrospective cohort study of 352 specimens J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-09 Julia S. Lehman MD, Heather D. Hardway PhD, Vahide Saeidi MD, Mark D.P. Davis MD, Michael J. Camilleri MD
-
The fate of nonscalp hair in alopecia areata universalis under baricitinib treatment: A real-world single-center experience J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-09 Federica Dall’Oglio MD PhD, Andrea Calogero Trecarichi MD, Maria Rita Nasca MD PhD, Francesco Lacarrubba MD, Anna Elisa Verzì MD, Giuseppe Micali MD
-
National trends in multimodality keloid treatment claims from 2017-2020: An IBM Marketscan study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-08 David H. Xiang BA, Debby Cheng BS, Helen Ji BA, Yevgeniy Semenov MD MA, Nicholas Theodosakis MD PhD
-
Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-06 Khalaf Kridin MD PhD, Ralf J. Ludwig MD
-
Presence of an undisclosed glucocorticoid in Skin-Cap products distributed in Asia J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-06 Lihong Chen MD, Han Cao PhD, Yunchen Le PhD, Xia Li MD, Jie Zheng MD PhD
-
Comments on the risk of cutaneous T cell lymphoma among patients with atopic dermatitis receiving dupilumab J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-06 Tai-Li Chen MD, Sheng-Hsiang Ma MD
-
This Month in JAAD Reviews: November 2024: Permanent drug-induced alopecia J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-06 Shari R. Lipner MD PhD
-
This Month in JAAD Reviews: October 2024: A link between incontinentia pigmenti and squamous cell carcinoma J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-06 Shari R. Lipner MD PhD
-
Boosting GPT-4V's accuracy in dermoscopic classification with few-shot learning. Comment on “can ChatGPT vision diagnose melanoma? An exploratory diagnostic accuracy study” J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-08-03 Jinge Wang PhD, Gangqing Hu PhD
-
Ethical considerations for dermatologists providing unsolicited advice about malignant nail conditions J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-31 Rachel C. Hill BS, Jane M. Grant-Kels MD, Shari R. Lipner MD PhD
-
Cutaneous lupus erythematosus: Expanding clinical trial eligibility criteria based on quality of life data J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-31 Daniella F. Faden MPH, Lillian Xie BS, Caroline J. Stone BA, Lais Lopes Almeida Gomes MD, Ahmed Eldaboush MD, Cristina Ricco BS, Rui Feng PhD, Victoria P. Werth MD
-
JAAD Game Changer: Delivering value in dermatology: Insights from skin cancer detection in routine clinical visits J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-31 Eliot N. Mostow MD
-
Ethical considerations when graduating residents and fellows face employment decisions J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-31 Albert E. Zhou MD PhD, Ekaterina Korytnikova MD, Christian Gronbeck MD, Brett Sloan MD, Hao Feng MD, Jane M. Grant-Kels MD
-
Characteristics of pruritus in lichen planopilaris and frontal fibrosing alopecia: A cohort study in a French hospital J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-31 Ambre Folliat MD, Emilie Brenaut MD PhD, Laurent Misery MD PhD, Claire Abasq-Thomas MD
-
Taking hydroxychloroquine to heart J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-31 Warren R. Heymann MD
-
This month in JAAD: October 2024 J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-31 Dirk M. Elston MD
-
Clinical features of hidradenitis suppurativa among elderly: Insights from a large multicenter tertiary cohort J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-30 Nicole D.K. Koerts MD, Johanna C. van Huijstee MD, Deveny A.Y. van der Weijden BS, Colin C. Spence BS, Barbara Horváth MD PhD, Hessel H. van der Zee MD PhD
-
Vancomycin-associated drug induced hypersensitivity syndrome: A retrospective cohort study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-29 Rachel L. Ziebart BSN, Hannah Haberecht BS, Mark D. Davis MD, David A. Wetter MD, Julio C. Sartori-Valinotti MD, Hafsa M. Cantwell MD, Marian T. McEvoy MD, Nessa Aghazadeh Mohandesi MD, Olivia C. Iverson BS, Austin Todd MS, Elizabeth Phillips MD, Afsaneh Alavi MD
-
Interleukin 23 versus interleukin 12/23 inhibitors on preventing incidental psoriatic arthritis in patients with psoriasis? A real-world comparison from the TriNetX Global Collaborative Network J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-28 Sung Huang Laurent Tsai MD MPH, Chi-Ya Yang MD MPH, An-Ping Huo MD, James Cheng-Chung Wei MD PhD
Managing psoriasis (PsO) and its comorbidities, particularly psoriatic arthritis, often involves using interleukin (IL)-23 and IL-12/23 inhibitors. However, the comparative risk of these treatments still needs to be explored. This study evaluates the risk of developing psoriatic arthritis in patients treated with IL-23 inhibitors compared to IL-12/23 inhibitors. This retrospective cohort study utilized
-
Impact of wrinkles on the dermatoscopic pattern of solar lentigines: A longitudinal clinical study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-27 Romain de Dormael MSc, Thierry Passeron MD PhD, Audrey Gueniche PharmD PhD, Edouard Raynaud MD, Christine Duval PhD, Philippe Bastien PhD, Virginie Hourblin MSc
-
Prospective evaluation of blood pressure, heart rate, and side effects in hypertensive patients using low-dose oral minoxidil for hair loss J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-26 Paulo Müller Ramos MD PhD, Daniel Fernandes Melo MD MSc, Bevin Bhoyrul MBBS MRCP, Baltazar Dias Sanabria MD, Juan Jimenez-Cauhe MD, David Saceda-Corralo MD PhD, Prateek Sharma MD, Monica Ramos MD, Hélio Amante Miot MD PhD, Sergio Vaño-Galvan MD PhD
-
Direct immunofluorescence testing for lichen planus: A retrospective cohort study of 1747 specimens J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-26 Burak Tekin MD, Heather Hardway PhD, Julia S. Lehman MD
-
Side effect profile and expectations with sclerotherapy across Fitzpatrick skin types J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-26 Michelle Lazar BS, Henriette De La Garza MD, Neelam A. Vashi MD
-
Evaluation of private and Medicaid insurance coverage for port-wine stain treatment with pulsed dye laser J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-25 Sophia Ly BA, Priya Manjaly BA, Lisa Y. Shen MD
-
Topical nanoencapsulated cannabidiol cream as an innovative strategy combating UV-A–induced nuclear and mitochondrial DNA injury: A pilot randomized clinical study J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-25 Erika McCormick MD, Haowei Han DO, Sara Abdel Azim MS, Cleo Whiting BS, Nitish Bhamidipati, Alexi Kiss MD, Tatiana Efimova PhD, Brian Berman MD PhD, Adam Friedman MD
UV-A radiation contributes to photoaging/photocarcinogenesis by generating inflammation and oxidative damage. Current photoprotective strategies are limited by the availability/utilization of UV-A filters, highlighting an unmet need. Cannabidiol (CBD), having anti-inflammatory/antioxidant properties via regulation of nuclear erythroid 2–related factor, heme oxygenase 1, and peroxisome proliferator-activated
-
Increasing survival for melanoma with bony metastases in the era of novel therapies: A population-based retrospective analysis J. Am. Acad. Dermatol. (IF 12.8) Pub Date : 2024-07-25 Connor J. Tupper MD, Laura M. Cogua BS, Peter T. Silberstein MD